Alogliptin 45802-0150
Product NDC
45802-0150- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 8, 2016
- Listing Expires
- December 31, 2026
- Application
- NDA022271
Need to source Alogliptin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Alogliptin Benzoate | 25 mg/1 |
Drug Class
Dipeptidyl Peptidase 4 Inhibitor [EPC]Dipeptidyl Peptidase 4 Inhibitors [MoA]
Packaging Options(1)
30 TABLET, FILM COATED in 1 BOTTLE (45802-150-65)